GROUP ONE TRADING, L.P. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is and the CUSIP is 81750R902. A total of 4 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,717,960
-38.2%
1,142,000
+24.3%
0.01%
-35.7%
Q2 2023$4,400,573
+3839.7%
918,700
+4563.5%
0.01%
Q1 2023$111,699
-20.2%
19,700
-21.2%
0.00%
Q4 2022$140,000
-28.2%
25,000
-17.5%
0.00%
Q3 2022$195,000
+124.1%
30,300
+19.3%
0.00%
Q2 2022$87,000
-2.2%
25,400
+103.2%
0.00%
Q1 2022$89,000
-75.1%
12,500
-70.8%
0.00%
Q4 2021$357,000
-56.1%
42,800
-63.4%
0.00%
-100.0%
Q3 2021$813,000
-82.7%
116,800
-40.9%
0.00%
-83.3%
Q2 2021$4,710,000
+9.6%
197,500
-5.4%
0.01%0.0%
Q1 2021$4,297,000
+901.6%
208,700
+1092.6%
0.01%
+500.0%
Q4 2020$429,000
-96.8%
17,500
-96.3%
0.00%
-97.6%
Q3 2020$13,410,000
+33425.0%
473,700
+5472.9%
0.04%
Q2 2020$40,000
-66.7%
8,500
-71.5%
0.00%
-100.0%
Q3 2019$120,000
-67.4%
29,800
-73.9%
0.00%
-66.7%
Q2 2019$368,000
+36700.0%
114,300
+114200.0%
0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,000
-99.2%
100
-99.4%
0.00%
-100.0%
Q1 2018$123,000
-33.5%
16,800
-7.7%
0.00%0.0%
Q4 2017$185,000
+2212.5%
18,200
+3540.0%
0.00%
Q3 2017$8,000
-82.6%
500
-87.8%
0.00%
Q2 2017$46,000
-72.3%
4,100
-72.1%
0.00%
-100.0%
Q1 2017$166,000
+130.6%
14,700
+101.4%
0.00%
+100.0%
Q4 2016$72,000
+5.9%
7,300
+32.7%
0.00%0.0%
Q3 2016$68,0005,5000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 100,000$95,0000.09%
GROUP ONE TRADING, L.P. 19,700$111,6990.00%
SIMPLEX TRADING, LLC 9,700$540.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SERES THERAPEUTICS INC shareholders